<DOC>
	<DOCNO>NCT02194439</DOCNO>
	<brief_summary>This study design collect longitudinal biological sample patient hematopoietic cell transplantation ( HCT ) care multiple bone marrow transplant center validate biomarkers acute chronic GVHD well use future unspecified research . The center include Dana-Farber Cancer Institute Boston 's Children 's Hospital , Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Fred Hutchinson Cancer Research Center , Texas Children 's Hospital , Children 's National Medical Center , Indiana University Simon Cancer Center .</brief_summary>
	<brief_title>Bridging Pediatric Adult Biomarkers Graft-Versus-Host Disease</brief_title>
	<detailed_description>After inform consent sign , study involve 1 ) collection basic HCT data clinical data available medical record 2 ) provide blood ( saliva occasional case ) sample processing , storage , DNA extraction , analysis ( include seven biomarker protein panel well future unspecified research purpose ) . Pediatric adult patient include ( adult patient Fred Hutchinson Cancer Research Center , Johns Hopkins Sidney Kimmel Comprehensive Cancer Center , Indiana University Simon Cancer Center ) . Primary Objective : 1 . To confirm ST2 alone seven-biomarker panel measure initiation GVHD therapy predict ) D180 post-therapy non-relapse mortality ; b ) D28 post-therapy non-response , c ) GVHD grade 1-4 onset D180 post-therapy non-relapse mortality . Secondary Objective : 1 . To demonstrate ST2 alone seven-biomarker panel measure day 14 day 21 post-HCT ( combination time point ) predict D180 post-HCT non-relapse mortality . 2 . To demonstrate ST2 alone seven-biomarker panel measure initiation GVHD symptoms/therapy diagnose acute GVHD compare complication present similar symptom ( drug rash , CMV , Clostridium enteritis ) . 3 . To demonstrate ST2 alone seven-biomarker panel measure initiation GVHD symptoms/therapy diagnose severity acute GVHD onset maximum . 4 . To develop repository biospecimens link clinical data future unspecified research .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>All patient receive allogeneic hematopoietic stem cell transplant , cord blood transplant , bone marrow transplant , T cell deplete marrow , donor lymphocyte infusion ( DLI ) , donor cellular infusion ( DCI ) include . patient receive allogeneic hematopoietic stem cell transplant , cord blood transplant , bone marrow transplant , T cell deplete marrow , donor lymphocyte infusion ( DLI ) , donor cellular infusion ( DCI ) exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Acute Graft Versus Host Disease</keyword>
	<keyword>Affect</keyword>
	<keyword>Anti-inflammatory</keyword>
	<keyword>Anti-inflammatory Agents</keyword>
	<keyword>Antigen-Presenting Cells</keyword>
	<keyword>Alloantigen</keyword>
	<keyword>Allogeneic</keyword>
	<keyword>Allograft rejection</keyword>
	<keyword>Allograft Tolerance</keyword>
	<keyword>Antigens</keyword>
	<keyword>Autoimmunity</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Biospecimen Repository</keyword>
	<keyword>BMT</keyword>
	<keyword>Bone Marrow Transplantation</keyword>
	<keyword>Cell Transplantation</keyword>
	<keyword>Cells</keyword>
	<keyword>Clonal Expansion</keyword>
	<keyword>Complex</keyword>
	<keyword>Cytokine</keyword>
	<keyword>Data</keyword>
	<keyword>Development</keyword>
	<keyword>Environment</keyword>
	<keyword>Failure ( biologic function )</keyword>
	<keyword>Genomics</keyword>
	<keyword>Graft-vs-Host Disease</keyword>
	<keyword>Graft-vs-Leukemia</keyword>
	<keyword>GVHD</keyword>
	<keyword>GVL</keyword>
	<keyword>Hematopoietic</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>HCT</keyword>
	<keyword>HSCT</keyword>
	<keyword>IL-33 Receptor</keyword>
	<keyword>Immune Reconstitution</keyword>
	<keyword>Immune Response</keyword>
	<keyword>Inflammatory</keyword>
	<keyword>Modeling</keyword>
	<keyword>Novel</keyword>
	<keyword>Novel therapeutic</keyword>
	<keyword>Outcome</keyword>
	<keyword>Pathway interaction</keyword>
	<keyword>Peptides</keyword>
	<keyword>Prevent</keyword>
	<keyword>Process</keyword>
	<keyword>Production</keyword>
	<keyword>Proteomics</keyword>
	<keyword>Regulatory T-Lymphocyte</keyword>
	<keyword>Response</keyword>
	<keyword>Role</keyword>
	<keyword>Signal</keyword>
	<keyword>ST2</keyword>
	<keyword>Transduction</keyword>
	<keyword>T-cell response</keyword>
	<keyword>T-cell Activation</keyword>
	<keyword>T-Lymphocytes</keyword>
	<keyword>Tissues</keyword>
</DOC>